ERBB2 and breast cancer: The interplay of EGFR, L1CAM, MAPK, and DAP12 signaling pathways plays a crucial role in the progression of TN BC, which is characterized by its lack of hormone receptors and HER2 expression, making it particularly aggressive and difficult to treat.